speb/financial-data huggingface dataset:
Financial ratios for 9165.T — annual report dated 2022-06-30
Total revenue: 23104275.569221757
Gross profit: 6417753.861922542
Operating income: 2549271.5425726627
Net income: 2397422.9445786662
Capital expenditures: 1233099.0555677575
Operating cash flow: 5022959.221026429
Depreciation & amortization: 2641064.4995973352
Net tangible assets: 16289237.865143862
Owner earnings: 3805388.3886082442
Return on net tangible assets (%): 23.36136546173909
Capex to operating income (%): 48.37064372998665
Buffett classification: The Good
Shares outstanding: 2350000
Book value: 16450281.865436709
Debt to equity: 0.17519751271059714
Current ratio: 3.203680001386826
Quick ratio: 3.037205949484852
Effective tax rate (%): 25.404566867431456
Interest coverage ratio: 45.16277561608301
COGS to revenue (%): 72.22262535834665
Free cash flow (dilution-adjusted): 3746299.1434219196
Retained earnings: 9535661.468628742
Inventory turnover: 19.778293618424478
Receivables turnover: 5.530071986317693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.869959830926195
FCF margin (%): 16.214744029509987
Revenue growth (%): 73.03513089166943
Rule of 40 score: 89.24987492117941
Financial ratios for 9165.T — annual report dated 2023-06-30
Total revenue: 22615029.700234838
Gross profit: 5990765.299074458
Operating income: 2102493.4383202097
Net income: 1451001.5195468988
Capital expenditures: 1638458.3506009118
Operating cash flow: 1870092.554220196
Depreciation & amortization: 2215133.305705208
Net tangible assets: 16288050.835750794
Owner earnings: 2027676.4746511946
Return on net tangible assets (%): 12.448858952482079
Capex to operating income (%): 77.9292967453901
Buffett classification: The Gruesome
Shares outstanding: 2350000
Book value: 16441269.512363585
Debt to equity: 0.10709609064484595
Current ratio: 4.25180202613937
Quick ratio: 4.009019865839487
Effective tax rate (%): 29.670039035560524
Interest coverage ratio: 129.03730394234844
COGS to revenue (%): 73.50980574209794
Free cash flow (dilution-adjusted): 104786.5727310402
Retained earnings: 10152534.880508358
Inventory turnover: 20.318093179918794
Receivables turnover: 6.056521546111045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.31659161283151
FCF margin (%): 0.4633492598506385
Revenue growth (%): -2.117555547331966
Rule of 40 score: -1.6542062874813273
Financial ratios for ADC.AX — annual report dated 2022-06-30
Operating income: -149303.4482758621
Net income: -149303.4482758621
Capital expenditures: 0
Net tangible assets: 7509995.862068966
Owner earnings: -149303.4482758621
Return on net tangible assets (%): -1.988062989887317
Buffett classification: The Gruesome
Shares outstanding: 119964226
Book value: 7775513.103448276
Debt to equity: 0
Current ratio: 69.40867283575957
Quick ratio: 69.40867283575957
Free cash flow (dilution-adjusted): -130481.37931034483
Retained earnings: -815315.1724137932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9201748654972897
Rule of 40 score: 0
Financial ratios for BALMLAWRIE.NS — annual report dated 2023-03-31
Total revenue: 269196345.91961026
Gross profit: 68032338.61144945
Operating income: 20875688.185140073
Net income: 20932070.645554204
Capital expenditures: 6083507.917174178
Operating cash flow: 25307746.65042631
Depreciation & amortization: 6917771.010962241
Net tangible assets: 204443239.95127895
Owner earnings: 21766333.739342265
Return on net tangible assets (%): 10.646639010675734
Capex to operating income (%): 29.141592187148095
Buffett classification: The Good
Shares outstanding: 171003846
Book value: 208524677.22289893
Debt to equity: 0.07071972951205954
Current ratio: 2.079188112431637
Quick ratio: 1.7599818482827267
Effective tax rate (%): 34.95876575381899
Interest coverage ratio: 13.34538177627583
COGS to revenue (%): 74.72761438159867
SG&A to revenue (%): 2.6624291548534864
Free cash flow (dilution-adjusted): 18929914.73812424
Retained earnings: 146609975.63946408
Inventory turnover: 8.05731253546145
Receivables turnover: 6.126364716428932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.486344137586308
FCF margin (%): 7.032010287308006
Rule of 40 score: 7.032010287308006
Financial ratios for BALMLAWRIE.NS — annual report dated 2024-03-31
Total revenue: 262982479.9136587
Gross profit: 74001211.17640005
Operating income: 34333421.273534
Net income: 28751864.731982253
Capital expenditures: 6257153.13586761
Operating cash flow: 32884578.48662909
Depreciation & amortization: 7094555.702122557
Net tangible assets: 218139321.26154214
Owner earnings: 29589267.298237197
Return on net tangible assets (%): 13.564389550273056
Capex to operating income (%): 18.224671191422892
Buffett classification: The Great
Shares outstanding: 171003846
Book value: 221597913.41887516
Debt to equity: 0.06119497484989759
Current ratio: 2.0839063435363157
Quick ratio: 1.8123911289982602
Effective tax rate (%): 27.389655119651252
Interest coverage ratio: 18.660878860167116
COGS to revenue (%): 71.86078281690256
SG&A to revenue (%): 2.745471990130099
Free cash flow (dilution-adjusted): 26578318.743254587
Retained earnings: 161327964.98381102
Inventory turnover: 8.156224995626662
Receivables turnover: 5.136301974644173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.24579920233665
FCF margin (%): 10.106497874679967
Revenue growth (%): -2.3083025086110163
Rule of 40 score: 7.798195366068951
Financial ratios for BALMLAWRIE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 212957465.36072624
Buffett classification: The Gruesome
Shares outstanding: 171003846
Book value: 216087004.30004776
Debt to equity: 0.06838745254218664
Current ratio: 1.9153797916279336
Quick ratio: 1.6719981161669648
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BALMLAWRIE.NS — annual report dated 2025-03-31
Total revenue: 294088870.7037643
Gross profit: 100530874.44470422
Operating income: 29495756.371288285
Net income: 31091571.19476268
Capital expenditures: 7701531.4472761275
Operating cash flow: 18258440.495674536
Depreciation & amortization: 7045990.180032733
Net tangible assets: 229728489.59551084
Owner earnings: 30436029.927519288
Return on net tangible assets (%): 13.248696311506173
Capex to operating income (%): 26.11064232539207
Buffett classification: The Good
Shares outstanding: 171003846
Book value: 232533130.6990881
Debt to equity: 0.05311322513368436
Current ratio: 2.268974737866985
Quick ratio: 1.9922542685578342
Effective tax rate (%): 29.364909877556173
Interest coverage ratio: 9.512033930254477
COGS to revenue (%): 65.81615815514182
SG&A to revenue (%): 2.5665436043574186
Free cash flow (dilution-adjusted): 10322726.209960252
Retained earnings: 173123626.37362635
Inventory turnover: 8.589697416805706
Receivables turnover: 5.255669516824232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.767022667416143
FCF margin (%): 3.510070335289339
Revenue growth (%): 11.828312973669702
Rule of 40 score: 15.338383308959042
Financial ratios for BALMLAWRIE.NS — quarterly report dated 2025-03-31
Total revenue: 71096703.2967033
Gross profit: 26876513.911620293
Operating income: 9171732.522796351
Net income: 8785924.713584287
Capital expenditures: 0
Depreciation & amortization: 1889501.9873743276
Net tangible assets: 229728489.59551084
Owner earnings: 10675426.700958615
Return on net tangible assets (%): 4.646975531748425
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 171003846
Book value: 232533130.6990881
Debt to equity: 0.05311322513368436
Current ratio: 2.268974737866985
Quick ratio: 1.9922542685578342
Effective tax rate (%): 34.71326188762408
Interest coverage ratio: 12.940390578610542
COGS to revenue (%): 62.19724309936247
Retained earnings: 173123626.37362635
Inventory turnover: 1.9623991458525287
Receivables turnover: 1.270570951457625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3480155833045
Rule of 40 score: 0
Financial ratios for BALMLAWRIE.NS — quarterly report dated 2025-06-30
Total revenue: 79646419.37748654
Gross profit: 27281558.623917624
Operating income: 8035654.1071846485
Net income: 8066276.620641236
Capital expenditures: 0
Depreciation & amortization: 1696220.4540135737
Owner earnings: 9762497.07465481
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 171003846
Effective tax rate (%): 27.219287878703014
Interest coverage ratio: 10.210946560799357
COGS to revenue (%): 65.74666025522646
Capitalized R&D asset: 0
Revenue growth (%): 12.02547471871272
Rule of 40 score: 12.02547471871272
Financial ratios for BALMLAWRIE.NS — quarterly report dated 2025-09-30
Total revenue: 71638962.79594137
Gross profit: 25029706.877113868
Operating income: 5849751.972942502
Net income: 6377001.127395716
Capital expenditures: 0
Depreciation & amortization: 1755997.7452085682
Net tangible assets: 218722401.35287485
Owner earnings: 8132998.8726042835
Return on net tangible assets (%): 3.7184114760531295
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 171003846
Book value: 221118590.75535512
Debt to equity: 0.12098462776559014
Current ratio: 1.981508878634294
Quick ratio: 1.727943531760183
Effective tax rate (%): 30.676819896101183
Interest coverage ratio: 7.30992364261362
COGS to revenue (%): 65.06132152079134
Inventory turnover: 1.9335906003229009
Receivables turnover: 1.1408600505726225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1735236549402543
Revenue growth (%): -10.053755892771022
Rule of 40 score: -10.053755892771022
Financial ratios for BALMLAWRIE.NS — quarterly report dated 2025-12-31
Total revenue: 73186420.85329175
Gross profit: 26055764.73209313
Operating income: 7646106.717166091
Net income: 7416820.764175114
Capital expenditures: 0
Depreciation & amortization: 1961880.3609223573
Owner earnings: 9378701.125097472
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 171003846
Effective tax rate (%): 28.315161552498815
Interest coverage ratio: 6.832548601917199
COGS to revenue (%): 64.39808856847355
Capitalized R&D asset: 0
Revenue growth (%): 2.1600788131986355
Rule of 40 score: 2.1600788131986355
Financial ratios for KRONOX.NS — annual report dated 2023-03-31
Total revenue: 11641656.516443362
Gross profit: 4956881.851400731
Operating income: 2497076.7356881853
Net income: 2023995.1278928139
Capital expenditures: 1022411.6930572473
Operating cash flow: 2395249.695493301
Depreciation & amortization: 182338.6114494519
Net tangible assets: 5442021.924482339
Owner earnings: 1183922.0462850183
Return on net tangible assets (%): 21.75518700060431
Capex to operating income (%): 40.94434417833276
Buffett classification: The Good
Shares outstanding: 37104000
Book value: 5442021.924482339
Debt to equity: 0
Current ratio: 3.854307622913847
Quick ratio: 2.819914298601714
Effective tax rate (%): 25.57556212487683
Interest coverage ratio: 220.44086021505376
COGS to revenue (%): 57.42116386616167
SG&A to revenue (%): 7.676452740170332
Free cash flow (dilution-adjusted): 1370280.1461632156
Retained earnings: 670645.5542021925
Inventory turnover: 5.982993568080236
Receivables turnover: 5.152175084901083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 45.39033786476553
FCF margin (%): 11.770491117202702
Rule of 40 score: 11.770491117202702
Financial ratios for KRONOX.NS — annual report dated 2024-03-31
Total revenue: 10776160.211056482
Gross profit: 5276999.640244634
Operating income: 3282443.938122077
Net income: 2560414.917855858
Capital expenditures: 1471435.42391174
Operating cash flow: 2088391.8935124115
Depreciation & amortization: 154550.90538433864
Net tangible assets: 7951193.18863173
Owner earnings: 1243530.3993284563
Return on net tangible assets (%): 15.639544529070202
Capex to operating income (%): 44.82743503468836
Buffett classification: The Good
Shares outstanding: 37104000
Book value: 7951193.18863173
Debt to equity: 0
Current ratio: 6.074528412572188
Quick ratio: 4.868333572331799
Effective tax rate (%): 25.36624242784386
COGS to revenue (%): 51.03079819813403
SG&A to revenue (%): 5.3419450181611
Free cash flow (dilution-adjusted): 616956.4696006716
Retained earnings: 3229320.0623575966
Inventory turnover: 4.95617448068651
Receivables turnover: 5.092363924857621
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.27101636981272
FCF margin (%): 5.725197635496047
Revenue growth (%): -7.434477251277792
Rule of 40 score: -1.7092796157817443
Financial ratios for LSH — annual report dated 2022-06-30
Total revenue: 9605536
Gross profit: 1808905
Operating income: -116565
Net income: -2889
Capital expenditures: 124299
Operating cash flow: 261545
Depreciation & amortization: 105223
Net tangible assets: 106385
Owner earnings: -21965
Return on net tangible assets (%): -20.64670771255346
Buffett classification: The Gruesome
Shares outstanding: 34427559
Book value: 106385
Debt to equity: 36.96837900079898
Current ratio: 0.6215403893651025
Quick ratio: 0.6215403893651025
Interest coverage ratio: -1.697194274981436
COGS to revenue (%): 81.16809931272965
SG&A to revenue (%): 17.78882511085274
Free cash flow (dilution-adjusted): 137246
Retained earnings: -2889
Receivables turnover: 7.999307126272906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.399617276891111
FCF margin (%): 1.428821879382889
Rule of 40 score: 1.428821879382889
Financial ratios for LSH — annual report dated 2023-06-30
Total revenue: 12872891
Gross profit: 2564289
Operating income: 248055
Net income: 983602
Capital expenditures: 18288
Operating cash flow: 39303
Depreciation & amortization: 162535
Net tangible assets: 861828
Owner earnings: 1127849
Return on net tangible assets (%): 130.8670639617186
Capex to operating income (%): 7.372558505170225
Buffett classification: The Great
Shares outstanding: 34427559
Book value: 854760
Debt to equity: 3.7641291122654312
Current ratio: 0.8779713995918347
Quick ratio: 0.8779713995918347
Effective tax rate (%): 6.450052438644803
Interest coverage ratio: 2.006917475728155
COGS to revenue (%): 80.07992920937495
SG&A to revenue (%): 16.83527810497269
Free cash flow (dilution-adjusted): 21015
Retained earnings: 862072
Receivables turnover: 5.691446531871133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.195464082622202
FCF margin (%): 0.16325004227877016
Revenue growth (%): 34.0153324083112
Rule of 40 score: 34.17858245058997
Financial ratios for MMED — annual report dated 2023-04-30
Total revenue: 2245000000
Gross profit: 1308000000
Operating income: -69000000
Net income: -92000000
Capital expenditures: 167000000
Operating cash flow: -6000000
Depreciation & amortization: 115000000
Owner earnings: -144000000
Buffett classification: The Gruesome
Shares outstanding: 280842845
COGS to revenue (%): 41.73719376391982
R&D to revenue (%): 19.10913140311804
SG&A to revenue (%): 42.761692650334076
Free cash flow (dilution-adjusted): -208000000
Capitalized R&D asset: 429000000
ROCI (R&D-adjusted, %): 50.58275058275058
FCF margin (%): -9.265033407572384
Rule of 40 score: -9.265033407572384
Financial ratios for MMED — annual report dated 2024-04-30
Total revenue: 2469000000
Gross profit: 1436000000
Operating income: -61000000
Net income: -107000000
Capital expenditures: 148000000
Operating cash flow: 41000000
Depreciation & amortization: 129000000
Net tangible assets: 1033000000
Owner earnings: -126000000
Return on net tangible assets (%): -12.197483059051308
Buffett classification: The Gruesome
Shares outstanding: 280842845
Book value: 3448000000
Debt to equity: 0.002320185614849188
Current ratio: 1.7277992277992278
Quick ratio: 1.164092664092664
COGS to revenue (%): 41.798298906439854
R&D to revenue (%): 17.699473471040907
SG&A to revenue (%): 42.81085459700284
Free cash flow (dilution-adjusted): -145000000
Inventory turnover: 3.5342465753424657
Receivables turnover: 4.8698224852071
Capitalized R&D asset: 724430000
ROCI (R&D-adjusted, %): 2.030804671470837
Rosenberg metric: 0.29836829836829837
FCF margin (%): -5.87282300526529
Revenue growth (%): 9.977728285077951
Rule of 40 score: 4.1049052798126615
Financial ratios for MMED — quarterly report dated 2025-01-31
Total revenue: 687000000
Gross profit: 395000000
Operating income: 22000000
Net income: -7000000
Capital expenditures: 50000000
Operating cash flow: 24000000
Depreciation & amortization: 37000000
Owner earnings: -20000000
Capex to operating income (%): 227.27272727272728
Buffett classification: The Gruesome
Shares outstanding: 280842845
Effective tax rate (%): 133.33333333333331
COGS to revenue (%): 42.503639010189225
R&D to revenue (%): 16.302765647743815
SG&A to revenue (%): 39.01018922852984
Free cash flow (dilution-adjusted): -36000000
Capitalized R&D asset: 112000000
ROCI (R&D-adjusted, %): 86.3095238095238
FCF margin (%): -5.240174672489083
Rule of 40 score: -5.240174672489083
Financial ratios for MMED — quarterly report dated 2025-04-30
Total revenue: 724000000
Gross profit: 402000000
Operating income: -38000000
Net income: -209000000
Capital expenditures: 57000000
Operating cash flow: 83000000
Depreciation & amortization: 38000000
Net tangible assets: 945000000
Owner earnings: -228000000
Return on net tangible assets (%): -24.126984126984127
Buffett classification: The Gruesome
Shares outstanding: 280842845
Book value: 3331000000
Debt to equity: 0.003302311618132693
Current ratio: 1.3225352112676056
Quick ratio: 0.8859154929577465
COGS to revenue (%): 44.33701657458563
R&D to revenue (%): 15.05524861878453
SG&A to revenue (%): 45.16574585635359
Free cash flow (dilution-adjusted): 17000000
Retained earnings: 0
Inventory turnover: 1.0354838709677419
Receivables turnover: 1.2701754385964912
Capitalized R&D asset: 184040000
ROCI (R&D-adjusted, %): -0.07256156849086463
Rosenberg metric: 0.0625
FCF margin (%): 2.3480662983425415
Revenue growth (%): 5.385735080058224
Rule of 40 score: 7.733801378400766
Financial ratios for MMED — annual report dated 2025-04-30
Total revenue: 2715000000
Gross profit: 1528000000
Operating income: 33000000
Net income: -198000000
Capital expenditures: 193000000
Operating cash flow: 140000000
Depreciation & amortization: 143000000
Net tangible assets: 945000000
Owner earnings: -248000000
Return on net tangible assets (%): -26.24338624338624
Capex to operating income (%): 584.8484848484849
Buffett classification: The Gruesome
Shares outstanding: 280842845
Book value: 3331000000
Debt to equity: 0.003302311618132693
Current ratio: 1.3225352112676056
Quick ratio: 0.8859154929577465
COGS to revenue (%): 43.72007366482505
R&D to revenue (%): 16.058931860036832
SG&A to revenue (%): 39.77900552486188
Free cash flow (dilution-adjusted): -94000000
Retained earnings: 0
Inventory turnover: 3.829032258064516
Receivables turnover: 4.7631578947368425
Capitalized R&D asset: 870360000
ROCI (R&D-adjusted, %): 0.802501971861988
Rosenberg metric: 0.21052631578947367
FCF margin (%): -3.4622467771639043
Revenue growth (%): 9.963547995139733
Rule of 40 score: 6.501301217975828
Financial ratios for MMED — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 1369000000
Buffett classification: The Gruesome
Shares outstanding: 280842845
Book value: 3744000000
Debt to equity: 0
Current ratio: 2.545714285714286
Quick ratio: 1.5114285714285713
Retained earnings: -5000000
Capitalized R&D asset: 109990000
Rule of 40 score: 0
Financial ratios for MMED — quarterly report dated 2026-01-31
Total revenue: 790000000
Gross profit: 362000000
Operating income: -93000000
Net income: -111000000
Capital expenditures: 53000000
Operating cash flow: 66000000
Depreciation & amortization: 39000000
Net tangible assets: 1095000000
Owner earnings: -125000000
Return on net tangible assets (%): -11.415525114155251
Buffett classification: The Gruesome
Shares outstanding: 280842845
Book value: 3463000000
Debt to equity: 0.0031764366156511693
Current ratio: 1.5919540229885059
Quick ratio: 1.007183908045977
COGS to revenue (%): 54.177215189873415
R&D to revenue (%): 14.430379746835442
SG&A to revenue (%): 39.11392405063291
Free cash flow (dilution-adjusted): 1000000
Inventory turnover: 1.0515970515970516
Receivables turnover: 1.209800918836141
Capitalized R&D asset: 149970000
ROCI (R&D-adjusted, %): -1.4046287785611506
FCF margin (%): 0.12658227848101267
Rule of 40 score: 0.12658227848101267
Financial ratios for NXI.PA — annual report dated 2022-12-31
Total revenue: 4629522340.425532
Gross profit: 1561901063.8297873
Operating income: 354436170.212766
Net income: 217134042.5531915
Capital expenditures: 73547872.34042554
Operating cash flow: 286419148.9361702
Depreciation & amortization: 182998936.17021278
Net tangible assets: 456130851.06382984
Owner earnings: 326585106.38297874
Return on net tangible assets (%): 71.59899524912363
Capex to operating income (%): 20.750667827235343
Buffett classification: The Great
Shares outstanding: 55698282
Book value: 2165662765.957447
Debt to equity: 1.3125936092484094
Current ratio: 1.1905310520929857
Quick ratio: 0.8371125763958461
Effective tax rate (%): 29.55876623700956
Interest coverage ratio: 6.084407757770554
COGS to revenue (%): 66.2621551646682
Free cash flow (dilution-adjusted): 200346808.51063833
Retained earnings: 199755319.14893618
Inventory turnover: 1.4612169155857484
Receivables turnover: 12.13031637630662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.278131463356017
FCF margin (%): 4.3275913534574935
Rule of 40 score: 4.3275913534574935
Financial ratios for NXI.PA — annual report dated 2023-12-31
Total revenue: 4404790000
Gross profit: 1510037777.7777777
Operating income: 235855555.55555555
Net income: 40812222.222222224
Capital expenditures: 66375555.55555555
Operating cash flow: 265384444.44444445
Depreciation & amortization: 232323333.3333333
Net tangible assets: 664911111.111111
Owner earnings: 206759999.99999997
Return on net tangible assets (%): 31.095885832692755
Capex to operating income (%): 28.1424600744335
Buffett classification: The Good
Shares outstanding: 55698282
Book value: 2156495555.5555544
Debt to equity: 1.3354779307580311
Current ratio: 1.2245172534867999
Quick ratio: 0.8460856377215584
Effective tax rate (%): 37.1750477682526
Interest coverage ratio: 2.356565566854656
COGS to revenue (%): 65.71827992304338
Free cash flow (dilution-adjusted): 196751111.1111111
Retained earnings: 21340000
Inventory turnover: 1.3641272163401401
Receivables turnover: 14.32281245596731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.153063951631185
FCF margin (%): 4.466753491338092
Revenue growth (%): -4.854331049731485
Rule of 40 score: -0.38757755839339314
Financial ratios for NXI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 581070833.3333334
Buffett classification: The Gruesome
Shares outstanding: 55698282
Book value: 1948700000
Debt to equity: 1.1878779228887635
Current ratio: 1.3027023215804985
Quick ratio: 0.7796580851073831
Retained earnings: -64818750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXI.PA — annual report dated 2024-12-31
Total revenue: 3471825000
Gross profit: 807862500
Operating income: -13562500
Net income: -63685416.66666667
Capital expenditures: 49112500
Operating cash flow: 241092708.33333334
Depreciation & amortization: 212180208.33333334
Net tangible assets: 581070833.3333334
Owner earnings: 99382291.66666669
Buffett classification: The Gruesome
Shares outstanding: 55698282
Book value: 1948700000
Debt to equity: 1.1878779228887635
Current ratio: 1.3027023215804985
Quick ratio: 0.7796580851073831
Interest coverage ratio: -0.11740518314126494
COGS to revenue (%): 76.73089801473289
Free cash flow (dilution-adjusted): 191020833.33333334
Retained earnings: -64818750
Inventory turnover: 1.5321962003702572
Receivables turnover: 19.144004273430635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3937831857604128
FCF margin (%): 5.50202943216704
Revenue growth (%): -21.180691928559593
Rule of 40 score: -15.678662496392553
Financial ratios for NXI.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 609738823.5294118
Buffett classification: The Gruesome
Shares outstanding: 55698282
Book value: 2156357647.0588236
Debt to equity: 1.097671782046414
Current ratio: 1.4053733479608825
Quick ratio: 0.7634003221309044
Retained earnings: -52223529.4117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLYX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -3781000
Net income: -3779000
Capital expenditures: 0
Operating cash flow: -173000
Net tangible assets: 1277000
Owner earnings: -3779000
Return on net tangible assets (%): -295.92795614722
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 1277000
Debt to equity: 0.10023492560689115
Current ratio: 2.2302504816955686
Quick ratio: 2.2302504816955686
Free cash flow (dilution-adjusted): -3410000
Retained earnings: -60294000
Capitalized R&D asset: 2771000
ROCI (R&D-adjusted, %): -47.76844532279315
Rule of 40 score: 0
Financial ratios for PLYX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -4352000
Net income: -30356000
Capital expenditures: 0
Operating cash flow: -2573000
Net tangible assets: 4712000
Owner earnings: -30356000
Return on net tangible assets (%): -644.2275042444821
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 4712000
Debt to equity: 0
Current ratio: 17.304498269896193
Quick ratio: 17.304498269896193
Free cash flow (dilution-adjusted): -4973000
Retained earnings: -90650000
Capitalized R&D asset: 4667570
ROCI (R&D-adjusted, %): -36.26676560510415
Rule of 40 score: 0
Financial ratios for PLYX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5052000
Net income: -5052000
Capital expenditures: 0
Operating cash flow: -709000
Net tangible assets: 4253000
Owner earnings: -5052000
Return on net tangible assets (%): -118.78673877263108
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 4253000
Debt to equity: 0
Current ratio: 23.98918918918919
Quick ratio: 23.98918918918919
Free cash flow (dilution-adjusted): -5160000
Retained earnings: -95704000
Capitalized R&D asset: 4716000
ROCI (R&D-adjusted, %): -21.273274612554356
Rule of 40 score: 0
Financial ratios for PLYX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -884000
Net income: -1008000
Capital expenditures: 0
Operating cash flow: -858000
Net tangible assets: 3247000
Owner earnings: -1008000
Return on net tangible assets (%): -31.044040652910375
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 3247000
Debt to equity: 0
Current ratio: 11.969594594594595
Quick ratio: 11.969594594594595
Free cash flow (dilution-adjusted): -967000
Retained earnings: -96710000
Capitalized R&D asset: 3635720
ROCI (R&D-adjusted, %): -31.072986648689284
Rule of 40 score: 0
Financial ratios for PLYX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -974000
Net income: -1430000
Capital expenditures: 0
Operating cash flow: -887000
Net tangible assets: 5301000
Owner earnings: -1430000
Return on net tangible assets (%): -26.97604225617808
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 5301000
Debt to equity: 0
Current ratio: 8.772727272727273
Quick ratio: 8.772727272727273
Free cash flow (dilution-adjusted): -995000
Retained earnings: -98140000
Capitalized R&D asset: 2389200
ROCI (R&D-adjusted, %): -30.714415749915474
Rule of 40 score: 0
Financial ratios for PLYX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -7821000
Net income: -8985000
Capital expenditures: 0
Operating cash flow: -3944000
Net tangible assets: 4565000
Owner earnings: -8985000
Return on net tangible assets (%): -196.82365826944138
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 4565000
Debt to equity: 0
Current ratio: 8.545454545454545
Quick ratio: 8.545454545454545
Free cash flow (dilution-adjusted): -8669000
Retained earnings: -99635000
Capitalized R&D asset: 9063800
ROCI (R&D-adjusted, %): -40.38751271816546
Rule of 40 score: 0
Financial ratios for PLYX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -911000
Net income: -1495000
Capital expenditures: 0
Operating cash flow: -1490000
Net tangible assets: 4565000
Owner earnings: -1495000
Return on net tangible assets (%): -32.74917853231106
Buffett classification: The Gruesome
Shares outstanding: 49845993
Book value: 4565000
Debt to equity: 0
Current ratio: 8.545454545454545
Quick ratio: 8.545454545454545
Free cash flow (dilution-adjusted): -1547000
Retained earnings: -99635000
Capitalized R&D asset: 1061460
ROCI (R&D-adjusted, %): -15.421182531585877
Rule of 40 score: 0
Financial ratios for RALLIS.NS — annual report dated 2023-03-31
Total revenue: 359917174.17783195
Gross profit: 121947624.84774666
Operating income: 21672350.791717418
Net income: 11198538.367844094
Capital expenditures: 20401948.842874546
Operating cash flow: 26409257.00365408
Depreciation & amortization: 11127892.8136419
Net tangible assets: 178460414.12911084
Owner earnings: 1924482.33861145
Return on net tangible assets (%): 1.0783805181686645
Capex to operating income (%): 94.13814421401676
Buffett classification: The Gruesome
Shares outstanding: 194468890
Book value: 210725943.97076738
Debt to equity: 0.07901460064968845
Current ratio: 1.662985436893204
Quick ratio: 0.8611144822006472
Effective tax rate (%): 28.211134535800735
Interest coverage ratio: 14.536764705882351
COGS to revenue (%): 66.11786444303061
SG&A to revenue (%): 6.440445088191897
Free cash flow (dilution-adjusted): 3521315.4689403167
Retained earnings: 154375152.25334957
Inventory turnover: 2.464061849689112
Receivables turnover: 5.926671747763649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.836255887490879
FCF margin (%): 0.9783682806979546
Rule of 40 score: 0.9783682806979546
Financial ratios for RALLIS.NS — annual report dated 2024-03-31
Total revenue: 315690130.71111643
Gross profit: 125329176.16021106
Operating income: 25699724.187552463
Net income: 17732342.007434946
Capital expenditures: 8179637.84626454
Operating cash flow: 32266458.808010552
Depreciation & amortization: 13681496.582324019
Net tangible assets: 188108885.95754886
Owner earnings: 23234200.74349442
Return on net tangible assets (%): 12.351463688290492
Capex to operating income (%): 31.827726191031687
Buffett classification: The Good
Shares outstanding: 194468890
Book value: 219389615.061758
Debt to equity: 0.07308047597964461
Current ratio: 1.7482618430355883
Quick ratio: 0.9548864796920419
Effective tax rate (%): 24.42502299908004
Interest coverage ratio: 12.12160633484163
COGS to revenue (%): 60.2999384624735
SG&A to revenue (%): 6.580336860978371
Free cash flow (dilution-adjusted): 22377982.971579324
Retained earnings: 163843386.49718192
Inventory turnover: 1.9648475696550356
Receivables turnover: 4.545680589850293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.795766524106734
FCF margin (%): 7.088591246476786
Revenue growth (%): -12.288117000180524
Rule of 40 score: -5.199525753703738
Financial ratios for RALLIS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 199474438.6048734
Buffett classification: The Gruesome
Shares outstanding: 194468890
Book value: 229813664.59627327
Debt to equity: 0.035343035343035345
Current ratio: 1.8239631336405528
Quick ratio: 1.1437788018433177
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RALLIS.NS — quarterly report dated 2024-12-31
Total revenue: 60846252.47697867
Gross profit: 27975288.495162603
Operating income: 1748455.5309476627
Net income: 1282200.7226949527
Capital expenditures: 0
Depreciation & amortization: 3380347.359832148
Owner earnings: 4662548.082527101
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 194468890
Effective tax rate (%): 42.10526315789474
Interest coverage ratio: 7.499999999999999
COGS to revenue (%): 54.02298850574713
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RALLIS.NS — annual report dated 2025-03-31
Total revenue: 308611176.05798453
Gross profit: 122768295.53425297
Operating income: 21393500.11690437
Net income: 14628244.096329201
Capital expenditures: 7596446.107084405
Operating cash flow: 34499649.286883324
Depreciation & amortization: 14085807.809212064
Net tangible assets: 193335281.73953703
Owner earnings: 21117605.79845686
Return on net tangible assets (%): 10.922789471456472
Capex to operating income (%): 35.50819672131148
Buffett classification: The Good
Shares outstanding: 194468890
Book value: 222615150.80664015
Debt to equity: 0.033136405408953656
Current ratio: 1.9257282655820962
Quick ratio: 1.1505254247785783
Effective tax rate (%): 32.967268441634964
Interest coverage ratio: 14.651721377101682
COGS to revenue (%): 60.21910252816437
SG&A to revenue (%): 7.320085156031002
Free cash flow (dilution-adjusted): 25917699.321954638
Retained earnings: 168465045.59270516
Inventory turnover: 2.116862191565575
Receivables turnover: 4.875718006021092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.123769163654494
FCF margin (%): 8.39817263036676
Revenue growth (%): -2.242374393265323
Rule of 40 score: 6.155798237101438
Financial ratios for RALLIS.NS — quarterly report dated 2025-03-31
Total revenue: 50268880.05611409
Gross profit: 19990647.650222115
Operating income: -5845218.611176058
Net income: -3740939.9111526767
Capital expenditures: 0
Depreciation & amortization: 3507131.1667056344
Net tangible assets: 193335281.73953703
Owner earnings: -233808.74444704223
Return on net tangible assets (%): -0.12093433870080238
Buffett classification: The Gruesome
Shares outstanding: 194468890
Book value: 222615150.80664015
Debt to equity: 0.033136405408953656
Current ratio: 1.9257282655820962
Quick ratio: 1.1505254247785783
Interest coverage ratio: -25
COGS to revenue (%): 60.23255813953489
Retained earnings: 168465045.59270516
Inventory turnover: 0.3448872791190061
Receivables turnover: 0.7941931551631789
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.492833104823632
Revenue growth (%): -17.383769731532027
Rule of 40 score: -17.383769731532027
Financial ratios for RALLIS.NS — quarterly report dated 2025-06-30
Total revenue: 111982213.90124035
Gross profit: 40603791.247367196
Operating income: 14158670.723145332
Net income: 11116311.724783525
Capital expenditures: 0
Depreciation & amortization: 3393400.4212497077
Owner earnings: 14509712.146033233
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 194468890
Effective tax rate (%): 26.356589147286826
Interest coverage ratio: 30.25
COGS to revenue (%): 63.74085684430513
Capitalized R&D asset: 0
Revenue growth (%): 122.76647853749071
Rule of 40 score: 122.76647853749071
Financial ratios for RALLIS.NS — quarterly report dated 2025-12-31
Total revenue: 69399576.69600089
Gross profit: 29074300.991422527
Operating income: 3230477.8879358363
Net income: 222791.57847833354
Capital expenditures: 0
Depreciation & amortization: 3230477.8879358363
Owner earnings: 3453269.46641417
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 194468890
Effective tax rate (%): -100
Interest coverage ratio: 14.5
COGS to revenue (%): 58.10593900481541
Capitalized R&D asset: 0
Revenue growth (%): -38.026250528315195
Rule of 40 score: -38.026250528315195
Financial ratios for ROG.TO — annual report dated 2022-12-31
Total revenue: 48392647058.823524
Gross profit: 33880147058.82353
Operating income: 12850000000
Net income: 9949264705.882353
Capital expenditures: 2475735294.1176467
Operating cash flow: 13090441176.470587
Depreciation & amortization: 2826470588.235294
Net tangible assets: 5505147058.823529
Owner earnings: 10300000000
Return on net tangible assets (%): 187.09763590223054
Capex to operating income (%): 19.26642252231632
Buffett classification: The Great
Shares outstanding: 13869815423
Book value: 23540441176.47059
Debt to equity: 0.8291113540527877
Current ratio: 1.2414552663460479
Quick ratio: 0.9255479276038034
Effective tax rate (%): 17.12500765602989
Interest coverage ratio: 25.327536231884057
COGS to revenue (%): 29.98906007840277
R&D to revenue (%): 23.13337587747288
SG&A to revenue (%): 21.577475916978152
Free cash flow (dilution-adjusted): 9200735294.117645
Retained earnings: 28630147058.82353
Inventory turnover: 2.293666472980825
Receivables turnover: 5.42885424399901
Capitalized R&D asset: 11194852941.17647
ROCI (R&D-adjusted, %): 36.2845922481842
FCF margin (%): 19.01267207585012
Rule of 40 score: 19.01267207585012
Financial ratios for ROG.TO — annual report dated 2023-12-31
Total revenue: 45788636363.63636
Gross profit: 33396969696.969696
Operating income: 11662878787.878788
Net income: 9362121212.121212
Capital expenditures: 2703787878.7878785
Operating cash flow: 12193181818.181818
Depreciation & amortization: 2624242424.242424
Net tangible assets: 3861363636.363636
Owner earnings: 9282575757.575758
Return on net tangible assets (%): 240.3963115558172
Capex to operating income (%): 23.182851575186746
Buffett classification: The Great
Shares outstanding: 13869815423
Book value: 25199242424.242424
Debt to equity: 0.9254126206295282
Current ratio: 1.3473251691911055
Quick ratio: 1.0351675797615214
Effective tax rate (%): 12.223879536898927
Interest coverage ratio: 15.441323971915748
COGS to revenue (%): 27.062755414371043
R&D to revenue (%): 23.49398587051836
SG&A to revenue (%): 24.620704488674907
Free cash flow (dilution-adjusted): 8042424242.424241
Retained earnings: 32081060606.060604
Inventory turnover: 2.110853013292038
Receivables turnover: 5.194310759711241
Capitalized R&D asset: 18258127228.163994
ROCI (R&D-adjusted, %): 22.214041793759858
Rosenberg metric: -0.04316067074687763
FCF margin (%): 17.5642361972833
Revenue growth (%): -5.381004870475194
Rule of 40 score: 12.183231326808105
Financial ratios for ROG.TO — annual report dated 2024-12-31
Total revenue: 43632867132.867134
Gross profit: 32246153846.153847
Operating income: 9382517482.517483
Net income: 6424475524.475525
Capital expenditures: 2425174825.174825
Operating cash flow: 14051748251.748253
Depreciation & amortization: 2393706293.7062936
Net tangible assets: 4606993006.993008
Owner earnings: 6393006993.006992
Return on net tangible assets (%): 138.7674559805707
Capex to operating income (%): 25.847805023477676
Buffett classification: The Good
Shares outstanding: 13869815423
Book value: 25287412587.412598
Debt to equity: 1.0053372417798176
Current ratio: 1.4815527513599527
Quick ratio: 1.2000888132331717
Effective tax rate (%): 22.097854659543795
Interest coverage ratio: 9.563079116179615
COGS to revenue (%): 26.096642359163397
R&D to revenue (%): 24.527606378716243
SG&A to revenue (%): 23.873707829152977
Free cash flow (dilution-adjusted): 9951048951.048952
Retained earnings: 30658741258.74126
Inventory turnover: 2.14080988693137
Receivables turnover: 5.1974177426072465
Capitalized R&D asset: 21603975130.261894
ROCI (R&D-adjusted, %): 12.449575043471864
Rosenberg metric: -0.10697724810400852
FCF margin (%): 22.80631460854235
Revenue growth (%): -4.70808786190728
Rule of 40 score: 18.09822674663507
Financial ratios for ROG.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4606993006.993008
Buffett classification: The Gruesome
Shares outstanding: 13869815423
Book value: 25287412587.412598
Debt to equity: 1.0053372417798176
Retained earnings: 30658741258.74126
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ROG.TO — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3172262773.7226276
Buffett classification: The Gruesome
Shares outstanding: 13869815423
Book value: 24119708029.197075
Debt to equity: 0.8008715651858129
Current ratio: 1.2944887599709936
Quick ratio: 1.0190355329949239
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYL.AX — annual report dated 2022-06-30
Total revenue: 389103448.2758621
Gross profit: 63793103.448275864
Operating income: 17448275.862068966
Net income: 12551724.137931034
Capital expenditures: 206896.55172413794
Depreciation & amortization: 11586206.896551725
Net tangible assets: 0
Owner earnings: 23931034.48275862
Capex to operating income (%): 1.1857707509881423
Buffett classification: The Great
Shares outstanding: 239144000
Book value: 0
Effective tax rate (%): 29.457364341085267
Interest coverage ratio: 13.31578947368421
COGS to revenue (%): 83.60510457284651
SG&A to revenue (%): 6.203473945409429
Free cash flow (dilution-adjusted): 24275862.068965517
Capitalized R&D asset: 0
FCF margin (%): 6.2389223679546255
Rule of 40 score: 6.2389223679546255
Financial ratios for SYL.AX — annual report dated 2023-06-30
Total revenue: 454437086.0927152
Gross profit: 72781456.95364238
Operating income: 10927152.317880794
Net income: 7682119.205298013
Capital expenditures: 13907284.76821192
Depreciation & amortization: 20132450.33112583
Net tangible assets: 0
Owner earnings: 13907284.768211924
Capex to operating income (%): 127.27272727272727
Buffett classification: The Gruesome
Shares outstanding: 239144000
Book value: 0
Effective tax rate (%): 30.952380952380953
Interest coverage ratio: 4.024390243902439
COGS to revenue (%): 83.98426114835326
SG&A to revenue (%): 6.033226464587584
Free cash flow (dilution-adjusted): 39735099.33774834
Capitalized R&D asset: 0
FCF margin (%): 8.74380647041679
Revenue growth (%): 16.79081439816324
Rule of 40 score: 25.534620868580028
Financial ratios for SYL.AX — annual report dated 2024-06-30
Total revenue: 495400000
Gross profit: 102400000
Operating income: 29000000
Net income: 23473164
Capital expenditures: 1355713.3333333333
Depreciation & amortization: 22933333.333333332
Net tangible assets: 48919208
Owner earnings: 45050783.99999999
Return on net tangible assets (%): 92.0922186638835
Capex to operating income (%): 4.67487356321839
Buffett classification: The Great
Shares outstanding: 239144000
Book value: -13437898.00000003
Debt to equity: -8.612390618433508
Current ratio: 1.039901560738926
Quick ratio: 0.9742793244198455
Effective tax rate (%): 30.627648952880744
Interest coverage ratio: 8.189542537801799
COGS to revenue (%): 79.32983447719015
SG&A to revenue (%): 6.028798277486207
Free cash flow (dilution-adjusted): 35439346.666666664
Retained earnings: 45702726
Inventory turnover: 34.96562603150821
Receivables turnover: 5.329596949499648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.48111943501188
FCF margin (%): 7.153683218947651
Revenue growth (%): 9.013990090352673
Rule of 40 score: 16.167673309300323
Financial ratios for ZBIO — annual report dated 2022-12-31
Total revenue: 0
Operating income: -75199000
Net income: -119282000
Capital expenditures: 198000
Operating cash flow: -65652000
Depreciation & amortization: 78000
Net tangible assets: -192286000
Owner earnings: -119402000
Buffett classification: The Gruesome
Shares outstanding: 63133377
Book value: -192286000
Debt to equity: -0.007941295778163777
Current ratio: 2.635806985789656
Quick ratio: 2.635806985789656
Free cash flow (dilution-adjusted): -68587000
Retained earnings: -193279000
Capitalized R&D asset: 61689000
ROCI (R&D-adjusted, %): -30.890925739567184
Rule of 40 score: 0
Financial ratios for ZBIO — annual report dated 2023-12-31
Total revenue: 6891798.76
Operating income: -27147000
Net income: -37124000
Capital expenditures: 17000
Operating cash flow: -30529000
Depreciation & amortization: 113000
Net tangible assets: -225721000
Owner earnings: -37028000
Buffett classification: The Gruesome
Shares outstanding: 63133377
Book value: -225721000
Debt to equity: -0.09353582520013645
Current ratio: 2.5713302949522743
Quick ratio: 2.5713302949522743
COGS to revenue (%): 0
R&D to revenue (%): 871.0788299337981
SG&A to revenue (%): 248.3241399811274
Free cash flow (dilution-adjusted): -34041000
Retained earnings: -230403000
Capitalized R&D asset: 101364630
ROCI (R&D-adjusted, %): -5.255435852203308
FCF margin (%): -493.934909962461
Rule of 40 score: -493.934909962461
Financial ratios for 2936.T — annual report dated 2022-02-28
Total revenue: 47981986.50285517
Gross profit: 28323706.523620006
Operating income: -3929858.1069389167
Net income: -4006497.6639557015
Capital expenditures: 98278.24883197785
Operating cash flow: -3227816.2311818656
Depreciation & amortization: 16551.306454403875
Net tangible assets: 5561835.957778162
Owner earnings: -4088224.606333276
Return on net tangible assets (%): -73.50494759946923
Buffett classification: The Gruesome
Shares outstanding: 53394065
Book value: 5563540.404914346
Debt to equity: 0.09330766335839161
Current ratio: 1.6777059950247126
Quick ratio: 1.4712938149621175
Interest coverage ratio: -248.203825136612
COGS to revenue (%): 40.970125274128435
SG&A to revenue (%): 67.22015277262369
Free cash flow (dilution-adjusted): -3327824.8831977854
Retained earnings: -4049939.435888562
Inventory turnover: 12.020633064750788
Receivables turnover: 16.210926629640458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -67.4873780522232
FCF margin (%): -6.935571296114977
Rule of 40 score: -6.935571296114977
Financial ratios for 411A.T — annual report dated 2025-01-31
Total revenue: 5918760.545100585
Gross profit: 4440791.6937053865
Operating income: 2283556.1323815705
Net income: 1286177.8066190786
Capital expenditures: 313939.0006489293
Operating cash flow: -16203335.496430889
Depreciation & amortization: 69247.24205061648
Net tangible assets: 6996534.717715769
Owner earnings: 1041486.0480207659
Return on net tangible assets (%): 14.8857411567421
Capex to operating income (%): 13.74781185350217
Buffett classification: The Great
Shares outstanding: 3700000
Book value: 7131148.604802072
Debt to equity: 2.720514873829524
Current ratio: 2.3852689552519393
Quick ratio: 2.3852689552519393
Effective tax rate (%): 37.4588609492195
COGS to revenue (%): 24.970918153102627
Free cash flow (dilution-adjusted): -16549993.510707334
Retained earnings: 1672147.95587281
Receivables turnover: 16.471881095138336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.50102962740367
FCF margin (%): -279.61924434343
Rule of 40 score: -279.61924434343
Financial ratios for AXISCADES.NS — annual report dated 2023-03-31
Total revenue: 99099232.64311816
Gross profit: 72372947.62484775
Operating income: 15846686.967113277
Net income: -584433.6175395859
Capital expenditures: 1292107.1863581
Operating cash flow: 8603751.522533497
Depreciation & amortization: 3230000
Net tangible assets: 24164993.90986602
Owner earnings: 1353459.196102314
Capex to operating income (%): 8.153800154187547
Buffett classification: The Great
Shares outstanding: 42530989
Book value: 41883398.29476249
Debt to equity: 1.006105052976086
Current ratio: 1.5027141703263374
Quick ratio: 1.3187887728643295
Effective tax rate (%): 122.82248858447487
Interest coverage ratio: 4.0120669185105235
COGS to revenue (%): 26.96921490251961
SG&A to revenue (%): 3.8790459297985866
Free cash flow (dilution-adjusted): 6617295.980511572
Retained earnings: 15767247.259439709
Inventory turnover: 3.331963634651858
Receivables turnover: 4.544533771846285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.813348410699096
FCF margin (%): 6.677444218304049
Rule of 40 score: 6.677444218304049
Financial ratios for AXISCADES.NS — annual report dated 2024-03-31
Total revenue: 114189627.05360354
Gross profit: 86947715.55342367
Operating income: 12126645.880801056
Net income: 4006403.6455210457
Capital expenditures: 2440424.511332294
Operating cash flow: 9465643.36251349
Depreciation & amortization: 4052188.511811968
Net tangible assets: 47082719.75056961
Owner earnings: 5618167.64600072
Return on net tangible assets (%): 11.932546963650609
Capex to operating income (%): 20.124480712312888
Buffett classification: The Great
Shares outstanding: 42530989
Book value: 70963161.05048567
Debt to equity: 0.5389367816577548
Current ratio: 1.9232696428234657
Quick ratio: 1.7221035711850612
Effective tax rate (%): 36.98848194398079
Interest coverage ratio: 1.9337980226798999
COGS to revenue (%): 23.856730425603214
SG&A to revenue (%): 3.3074035999597995
Free cash flow (dilution-adjusted): 6369648.638925531
Retained earnings: 19207938.60175081
Inventory turnover: 3.276453755866513
Receivables turnover: 4.067317253610164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.7288683485328
FCF margin (%): 5.578132447998498
Revenue growth (%): 15.227559293854254
Rule of 40 score: 20.80569174185275
Financial ratios for AXISCADES.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 50368741.04156713
Buffett classification: The Gruesome
Shares outstanding: 42530989
Book value: 73323494.98327759
Debt to equity: 0.41604227514126496
Current ratio: 1.704665157642825
Quick ratio: 1.5035812310536674
Capitalized R&D asset: 0
Rule of 40 score: 0